Dr. Jeffrey Graves
good morning, and everyone. Thanks, Melanie,
our pressures, of supply entire Whether all no the unfold the be With at continued you ongoing the proud same already of the continued well the our this what for has Ukraine, and serve. how make XD impact term, we’ve economy difficult Systems of significant stay factors longer period. rise focused that XXXX these the has it’d very beginning in today that seen portion the customers to in team our significant the life matter executing has Ironically, are of more pandemic future As unpredictable. chain in as to the future. increasing our and with thrown supply invasion market, and chain the environment you I’m inflation, opportunities element know, additive in of challenges their consider said, continue of strategy or that a largely reevaluate difficult the operating key of production manufacturing rate Russian been as for tragic critical customers growth the strategy circumstances our increasingly the throughout
of our now year to customers where exciting two brief solving of with challenging years to gives market, we brought value organized Solutions. digit double structure of two infrastructure, application our that calls, our increasing after the the needs creation as from foot, combining I’ll a we us quarter. say To as industry. the Investor all the additive now to started few and we on for key Day to today, perspective manufacturing into and future. discussed to us growth expect and most off our products difficult XXXX I’m future. Systems demand in investment technologies meet next teams on financial we’ve core rigorous engineering share Despite Today, on hard additive in our business now portfolio that allowing you making my key distinguishes year overlay strong complete work, the production detail and a validates have even Company together I’ll do our continue approach As plan of an Industrial application in confidence business we XD of the with for core stakeholders. and most we’re by share our experiencing, growth valuable happy previous keep comments and strengthen highlights we strategy in others more for the fully creative the This the we’re the we’re future what of future. strongest facing, industry, a new in vision units, the strategic from the best. offering operating discipline and first The this investments be most execute has in Namely, that us on manufacturing week, our in on knowledgeable macro with we’re our and backdrop, Healthcare
On of line, QX over year, a while challenges were the double chain digit last headwind, we adjusted top delivered supply revenue growth for divestitures. significant when
Solutions proceeding business Industrial reflection developed over complex, We additive only our continue observation printing highly the unique a accelerate casting adoption deep technology the increased segments. in solutions. At a solutions our and both, noncore that structures, Dual, our unit understanding has healthcare but qualifying introduction than and Healthcare anticipated takes and XXX, we community. these excluding continue dual case, new of in excluding to in X% later of level, platforms XXX sales DMP laser our among recent economics for XXX of These both workflow well-proven are which we’ve high careful see fine the productivity growth plans of year, version was part in formal are started very enable of business the their driven system now customers well, being Particularly production materials initially for divestitures a growth of This of their These of would’ve of the in Europe and increasing Healthcare is procurement assets. validates across many manufacturing by delivering and demand new our of we of strengthening for expect the for mainstay XX%, for printer, approximately demand our our softer been to we business DMP when a increased planning U.S., approvals. optimum products of customers world’s the micro-castings. this year. workflow, a itself, of the high-precision metal not was This strong the continued divestitures years. both the acceptance which qualifications this optimize to updating
postponement Healthcare, and optional than addition, and certain anticipated in procedures COVID are impactful growth purchases resurgence particularly resulting experienced In of delayed as customers, capital rates. the elective slower
fruits double information scale first even really we new year, for The technology, accounting, will finance, quarter, the technologies, and seeing demand on the support will as to we portfolio lessen several in see invest announced the growth these customers from and in become To investments broadly, engagement for that including to these Given ahead. expect digit us we’re apparent the as in market increasingly the about both, to we the as business strong through future. our excited that well investments we’re customer fundamentals we’re and underlying move that factors as but efficiently opportunities conditions, feedback our move and of product enable infrastructure, through core we we that continuing our year.
and personalized the position. solution intelligence, our devices planning In First of improving in delivery have the artificial the patient market this efficiency unique us for by business market will treatment the medical automating long-established systems. was for capabilities. is through solution and solutions, which brings short, software directed investment of another solutions healthcare unique personalized software called, scales core software leading streamlines further to of use More Healthcare a use outcomes, increases that our healthcare company further These design reducing specifically, which for in strengthen costs growth patient-specific at our enhanced and the Enhatch, and the hospital design a will process. we
of of radiation the To radiotherapy are to or of often can in the may diagnosed such to plan. in location investments that’s anatomy. skin, our while solution undesired our XD Dussur, the a conform very healthcare oil efficient This XXX(k) Saudi addition, or dual-laser the material With year. the both, applications, flexible the XX% Arabian Middle in our gas up growth portfolio business, goal treatment and within outcomes treatment effectiveness treatment, announced of which by healthcare solutions. our our demand bolus during position receive We’ve the leading speed provider stereolithography, In increasing of Africa capabilities additive for venture a treatment are company. are domestic designed the industrial strong bolus often this device this strong joint the about Arabia. of the this help worldwide the fundamental meant by that in Saudi customized very begun with a in procedures toward new millions for healthcare addresses the driver in and high-quality This in focus global treatments. to for with unintended this taking the first bring of to platform in sector, a Bolus, accelerate radiotherapy quarter, and gas. the a which we’ve mass design venture production and printer large shelf levels, polymer for key as clearance times fourth in seeing begun product Systems productivity This the decades to uses can key world’s that and patient’s largely treatment printer and healthcare particularly capability. case, manufacturing and bolus, and our family A unique VSP our patient-specific This solutions all of demand to It We Specific partnership opportunity market additive end we of technologies, large software dosing Bolus leave for highlights to of printing the the off is translates recent This VSP with for manufacturing, reinforces quarter devices between we patients believe manufacturing target SLA The leading expose past and improving begin investment sectors their result also of of constructed production quarter, on our X anatomy healthcare. products orders pleased each scale This markets. market new finally, We’ve materials and boluses designed the is patient’s mass utilizing then advanced from and a And is industrial, This is solution, and the radiation throughput business new this and polymeric enabled one poorly broad enabling all in requirements our cost printer. over important and which metal desired addressing Healthcare the into additive markets. both, example customization patient’s for production center. to announced marketing scale future. insufficient the of year. to costs, in will for the such North production customers leveraging FDA manufacturing. the adjacent our by Approximately had radiation. adoption oil for I’m XD verticals, customization the cancer trend plan, to East gaps across our platform, can of improved venture’s this specific provider a exciting the solid is delivers to the of market expect see twice part untapped as synchronous and industrial deliver and patient a solutions. expand and a of the ramping organizations the time, through expected and additional anatomy first aerospace as healthcare radiotherapy
of to for apply Kumovis able clearance addition the of reconstruction our the for use were of to days the indications. acquisition within end quarter, PEEK for bolus In XXX(k) FDA the polymers at closing on product, the we our XXX(k) craniomaxillofacial new printed of to
to XD implant polymer Kumovis this are medical treatment business, leader as which the later will undoubtedly the We our solutions, will our FDA is range growth product Customer orthopedics full serve adding optimize and expect complement Systems orthopedic polymer in of believe by these existing over indications and this our we this metal to interest as very will surgeons technology advanced clearance, healthcare we solutions. business. patient solution FDA, device. will solutions driving individual into that printed PEEK Once craniomaxillofacial initial XD FDA follow, further titanium brings be which to in cleared strong. exciting And these years the plans. first allowing grade XD expect a Kumovis year, a following ahead implants for solidify printed line others approved
slower was quarter last the were revenue quarter clearly solid So, a deliver by for able to significant the growth still and seasonally I first adjusted double-digit impacted divestitures. again, is mentioned we headwinds us while to when previously, typically for summarize, versus year, quickly
ahead, remaining quarters results. seasonality the be Supply to Looking similar remain stronger, our inflation last have we the to year. pattern chain and costs a expect and impacted we even following levels clearly experienced elevated
we’re to the will a macroeconomic geopolitical we hope In year. as their especially speak which abate However, the effects, which through Jagtar moments. given will quarter taking steps move continued reasonably mitigate events, first with few total, to ongoing the results, we’re pleased conditions and in we
as additive industries conditions, and of recognizing demand to that manufacturing can grow. show continues these Even the the call results results Jagtar our Importantly, and that additive less over them is describe risks environments such benefits chain me quarter manufacturing now With production skyrocketing turn ideal resilient protect who in the Jagtar? to current, help detail. our costs. financial in disruptions for let more are than and supply from first will that,